BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28627701)

  • 21. Bone morphogenetic protein 2 enhances mouse osteoclast differentiation via increased levels of receptor activator of NF-κB ligand expression in osteoblasts.
    Tachi K; Takami M; Zhao B; Mochizuki A; Yamada A; Miyamoto Y; Inoue T; Baba K; Kamijo R
    Cell Tissue Res; 2010 Nov; 342(2):213-20. PubMed ID: 20941510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Docosahexaenoic acid signaling attenuates the proliferation and differentiation of bone marrow-derived osteoclast precursors and promotes apoptosis in mature osteoclasts.
    Kim HJ; Ohk B; Yoon HJ; Kang WY; Seong SJ; Kim SY; Yoon YR
    Cell Signal; 2017 Jan; 29():226-232. PubMed ID: 27836739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of the bone resorption supernatant from RAW264.7 osteoclast on the osteogenic activity of mouse MC3T3-E1 cell].
    Chen LL; Wang K; Zhang J; Wu YM
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jan; 47(1):32-7. PubMed ID: 22490219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic low dose tumor necrosis factor-α (TNF) suppresses early bone accrual in young mice by inhibiting osteoblasts without affecting osteoclasts.
    Gilbert LC; Chen H; Lu X; Nanes MS
    Bone; 2013 Sep; 56(1):174-83. PubMed ID: 23756233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effects of iron on bone morphogenetic protein 2-induced osteoblastogenesis.
    Yang Q; Jian J; Abramson SB; Huang X
    J Bone Miner Res; 2011 Jun; 26(6):1188-96. PubMed ID: 21308772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
    Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
    J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
    J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Pasteurella multocida toxin on porcine bone marrow cell differentiation into osteoclasts and osteoblasts.
    Gwaltney SM; Galvin RJ; Register KB; Rimler RB; Ackermann MR
    Vet Pathol; 1997 Sep; 34(5):421-30. PubMed ID: 9381653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of protease-activated receptor-2 leads to inhibition of osteoclast differentiation.
    Smith R; Ransjö M; Tatarczuch L; Song SJ; Pagel C; Morrison JR; Pike RN; Mackie EJ
    J Bone Miner Res; 2004 Mar; 19(3):507-16. PubMed ID: 15040840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium hydrogen sulfide inhibits nicotine and lipopolysaccharide-induced osteoclastic differentiation and reversed osteoblastic differentiation in human periodontal ligament cells.
    Lee SK; Chung JH; Choi SC; Auh QS; Lee YM; Lee SI; Kim EC
    J Cell Biochem; 2013 May; 114(5):1183-93. PubMed ID: 23192567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gentian violet inhibits MDA-MB-231 human breast cancer cell proliferation, and reverses the stimulation of osteoclastogenesis and suppression of osteoblast activity induced by cancer cells.
    Yamaguchi M; Vikulina T; Weitzmann MN
    Oncol Rep; 2015 Oct; 34(4):2156-62. PubMed ID: 26260090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D-amino acid inhibits biofilm but not new bone formation in an ovine model.
    Harmata AJ; Ma Y; Sanchez CJ; Zienkiewicz KJ; Elefteriou F; Wenke JC; Guelcher SA
    Clin Orthop Relat Res; 2015 Dec; 473(12):3951-61. PubMed ID: 26201421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Fas/Fas ligand system inhibits differentiation of murine osteoblasts but has a limited role in osteoblast and osteoclast apoptosis.
    Kovacić N; Lukić IK; Grcević D; Katavić V; Croucher P; Marusić A
    J Immunol; 2007 Mar; 178(6):3379-89. PubMed ID: 17339432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mangiferin attenuates osteoclastogenesis, bone resorption, and RANKL-induced activation of NF-κB and ERK.
    Ang E; Liu Q; Qi M; Liu HG; Yang X; Chen H; Zheng MH; Xu J
    J Cell Biochem; 2011 Jan; 112(1):89-97. PubMed ID: 20683903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Icariin influences adipogenic differentiation of stem cells affected by osteoblast-osteoclast co-culture and clinical research adipogenic.
    Zhang S; Feng P; Mo G; Li D; Li Y; Mo L; Yang Z; Liang D
    Biomed Pharmacother; 2017 Apr; 88():436-442. PubMed ID: 28122309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
    Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
    J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoblastic NF-κB pathway is involved in 1α, 25(OH)2D3-induced osteoclast-like cells formation in vitro.
    Cong L; Zhang C; Tu G
    Int J Clin Exp Pathol; 2015; 8(5):5988-96. PubMed ID: 26191332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of CX3CL1 in the Migration of Osteoclast Precursors Across Osteoblast Layer Stimulated by Interleukin-1ß.
    Matsuura T; Ichinose S; Akiyama M; Kasahara Y; Tachikawa N; Nakahama KI
    J Cell Physiol; 2017 Jul; 232(7):1739-1745. PubMed ID: 27579490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
    O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
    J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.